Cervical Dysplasia Diagnostic Market (6.5% CAGR) 2017 to 2025: Global Industry Size, Share, Growth, Trends and Forecast

According to the latest market report published by Acute Market Reports, Inc. “Cervical Dysplasia Diagnostic Market – Growth, Future Prospects, and Competitive Analysis, 2017 – 2025,” the global cervical dysplasia diagnostic market was valued at US$ 437.3 Mn in 2016, and is expected to reach US$ 791.3 Mn by 2025, expanding at a CAGR of 6.5% from 2017 to 2025

Market Insights

Cervical dysplasia, also known as cervical intraepithelial neoplasia (CIN), causes abnormal cell growth that occurs on the epithelial lining of the cervix. It is the precancerous condition of the cervix which in an average of 10-15 years would progress to cervical cancer. It is common health problem observed in among women. WHO and national governments are taking initiatives for providing screening program and effective education to promote preventive practices among women. Annually around 250,000 to 1 million women in the U.S. are diagnosed with cervical dysplasia. The peak incidence in women ranges from age 25 -35 and if not diagnosed or treated at the earliest may progress in 30-40% cases into invasive cancer. Cervical cancer is a global burden, especially in developing countries where it is the most common cause of preventable cancer-related mortality. Thus rising incidence of cervical dysplasia and advancement in diagnostic technology and treatment option are the key factors contributing the growth of cervical dysplasia diagnostic market.

Browse Full Report Originally Published by Acute Market Reports at https://www.acutemarketreports.com/report/cervical-dysplasia-diagnostic-market

The global cervical dysplasia diagnostic market is segmented by diagnosis type into diagnostic test and diagnostic devices. Diagnostic test types is further segmented into HPV test, pap smear test and biopsy.

As of the current market scenario, North America dominates the global cervical dysplasia diagnostic market followed by the Europe. Rise in incidence of cervical dysplasia, advancement in diagnostic technology, awareness about cervical cancer and available novel treatment option are some of the major factors driving the growth of cervical dysplasia diagnostic market in North America and Europe. Asia Pacific is the fastest growing regional market for cervical dysplasia with highest CAGR in the forecast period.

Market Competition Assessment:

Key players in the global cervical dysplasia diagnostic market are Abbott Laboratories, Becton, Dickinson and Company, F. Hoffmann La-Roche Ltd., GlaxoSmithKline Plc, Helix BioPharma Corp., Hologic, Inc., Inovio Biomedical Corporation, Micromedic Technologies Ltd., OncoHealth Corporation, PDS Biotechnology Corporation, Photocure ASA, Quest Diagnostics, Inc., QIAGEN N.V. and others.

Key Market Movements:

• Increase in incidence and mortality of cervical cancer is leading to global burden especially in developing countries. In developed countries government is taking initiatives for screening programs with goal of early diagnosis and treatment of cervical dysplasia which play pivotal role in growth of cervical dysplasia diagnostic market.
• Advancement in diagnostic technology and novel drug treatment option available in market would further propel the growth of cervical dysplasia diagnostic market.

Table of Content

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase II-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Cervical Dysplasia Diagnostic Market Portraiture
2.1.1. Global Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2016
2.1.2. Global Cervical Dysplasia Diagnostic Market, by Geography, 2016

Chapter 3. Cervical Dysplasia Diagnostic: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.4.1. Attractive Investment Proposition, by Geography
3.5. Competitive Landscape
3.5.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Cervical Dysplasia Diagnostic Market, by Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global Cervical Dysplasia Diagnostic Market, by Type
4.3. Diagnostic Test
4.3.1. HPV Test
4.3.2. Pap Smear Test
4.3.3. Biopsy
4.4. Diagnostic Device
4.4.1. Colposcopy

Chapter 5. Global Cervical Dysplasia Diagnostic Market, by Geography, 2015 – 2025 (US$ Mn)
…………

About Us
Acute Market Reports is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives.

Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
(US/CANADA) Ph.: +1-855-455-8662
E-mail: sales@acutemarketreports.com